Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 342

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 342
---
 net tangible book value as of December 31, 2024, as adjusted to reflect the proforma adjustments presented in the Unaudited Pro Forma Condensed Combined Balance Sheet. (2)The calculation of adjusted net tangible book value per share excludes shares underlying NorthView warrants and NorthView Private Placement Warrants, as the exercise price of $11.50 per share. and the exercise of these warrants is not considered probable as of the Business Combination date. Should these warrants be exercised in the future, they would result in additional dilution to NorthView shareholders, as presented below. (3)Includes Sponsor and Representative shares in NorthView and has been reduced by the 710,220 Sponsor shares allocated to the senior secured convertible note holders. (4)Includes 7,152,683shares expected to be issued to existing Profusa common and preferred shareholders, 7,966,963shares expected to be issued to the holders of Profusa’s junior convertible notes and senior convertible notes, and 380,354shares reserved for Profusa option holders under each redemption scenario. (5)Includes 1,897,500shares issuable pursuant to outstanding NorthView Rights. (6)Represents $1,575,000 of transaction costs being paid in shares of New Profusa Common Stock at $10 per share. (7)Assumes 1,000,000shares issuable upon conversion of the $10 million first tranche of the PIPE Investor convertible note facility ($22.22 million total) at $10 per share.

178

(8)Senior secured convertible note which includes 710,220 Sponsor shares that were utilized as inducement shares for the notes. (9)Represents 1,385,901shares issued upon the conversion and exchange of Profusa bridge notes and 2,899,111shares issued in exchange for the shares issued pursuant to the Bridge Note Buyout Agreement. (10)Represents shares from the conversion of the NorthView working capital convertible loan at a $2.22 per share For purposes of Item 1604(c)(1) of Regulation S -K, New Profusa would have 33,002,012 total shares of Common Stock outstanding after giving effect to the de -SPACtransaction under the no redemptions scenario. Where redemptions are none, the company valuation is based on the NorthView offering price of the securities in the initial registered offering price per share of $10.00 and is therefore calculated as: $10.00 (per share IPO